Myeloid Leukemia Associated with Down Syndrome
Classification and Recognition
- The World Health Organization (WHO) classification specifically lists "Myeloid leukemia associated with Down syndrome" as a distinct entity under "Myeloid proliferations related to Down syndrome" 1, 4
- This classification also includes "Transient abnormal myelopoiesis" (also called transient myeloproliferative disorder), which is unique to newborns with Down syndrome 2, 3
- These conditions are considered separate from other types of Acute Myeloid Leukemia (AML) due to their unique clinical, biological, and genetic features 4
Clinical Management
- The American Academy of Pediatrics recommends that babies with Down syndrome undergo complete blood count screening to detect transient myelodysplasia of the newborn 5
- Referral to a pediatric hematologist/oncologist is recommended due to the significantly higher risk of developing leukemia compared to the general population 5